about
Diverse functions of matrix metalloproteinases during fibrosisIs there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?Mechanisms of alveolar epithelial injury, repair, and fibrosisPulmonary fibrosis: patterns and perpetratorsPotential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosisHistotripsy of the Prostate in a Canine Model: Characterization of Post-Therapy Inflammation and FibrosisFibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosisPharmacodynamic and pharmacokinetic assessment of pulmonary rehabilitation mixture for the treatment of pulmonary fibrosisMicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosisThe promotion of functional urinary bladder regeneration using anti-inflammatory nanofibersConversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats.Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1.Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungsProtective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts.Angiotensinogen gene transcription in pulmonary fibrosisPharmacologic therapies for idiopathic pulmonary fibrosis, past and future.A review of current and novel therapies for idiopathic pulmonary fibrosisEstablishment of a mouse model for pulmonary inflammation and fibrosis by intratracheal instillation of polyhexamethyleneguanidine phosphate.Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanibApolipoprotein A1 Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition of Alveolar Epithelial CellsMicroarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFJNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.Microvascular targets for anti-fibrotic therapeuticsGrainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.Palliative and end-of-life care for patients with idiopathic pulmonary fibrosis: challenges and dilemmas.Novel insights into TRPM7 function in fibrotic diseases: a potential therapeutic target.Translational models of lung disease.The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.Dissecting fibrosis: therapeutic insights from the small-molecule toolbox.Integrins and integrin-related proteins in cardiac fibrosis.The footprint of TGF-β in airway remodeling of the mustard lung.TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis.Lung Pericytes and Resident Fibroblasts: Busy Multitaskers.Plasma membrane wounding and repair in pulmonary diseases.Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts.The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.Notch intracellular domain expression in various skin fibroproliferative diseases.
P2860
Q26825368-5DE4FE46-C0D0-4B90-8F38-1E8FBB054D1DQ26998459-7963A856-6C23-4E95-8408-8112D27D89E9Q27023971-0F28B4F4-ACF8-4231-89E7-EC426B698A2AQ27694249-0011E0E2-B9BC-47DF-9508-67218900F246Q28389128-BEE11089-051A-412E-8BEC-38B821C0B043Q30380325-E9ABE66E-2517-4278-BDB0-299A54232722Q33698776-F07132B0-8586-41EE-BBB2-83C871C8596BQ33799369-2988B0A6-3178-451E-A68F-ABF87C1DA5DEQ33799699-2E965992-DD75-4F5D-9975-22EC03FA6808Q34722403-E61680CF-0630-44CD-8B11-DF871DD7C1ECQ34731282-4DD3AAA0-B3F0-4B5A-9670-95B10D1FAACEQ35153085-F7659DEE-0BE5-4C1D-A628-A67D922E5C37Q35351530-648F9E67-D19D-4684-8A57-9BA153EDFD83Q35750862-F3285F7B-D123-4BE4-8932-B8D12887F85AQ35766650-324F0D27-8E31-414C-9F1D-823F22D7E524Q35829724-715394B6-C011-4F5E-B3C0-DB1810010988Q36264068-111D5C4D-03AF-4F7C-B419-E23FFCDDC32DQ36542274-9CF0FEA2-D7AF-41C0-99D8-A7948C49CC85Q36898503-D00D4663-92BF-4F1C-A657-F07C7314ED0FQ36957621-40C3080D-DE97-4DB8-9D89-7DA25A02793EQ37092455-72F26501-D29F-42A6-857A-5B0A65D994F5Q37112937-B1836914-62E9-46BF-882E-0B039C130B78Q37156395-2B42976C-EC43-4FE7-A6C0-6B9EB8BE9875Q37230492-248FD64C-E97E-448C-8A16-1C4BA5604B4DQ37358577-0BCFBDFC-A24D-4CC1-A8A7-221A5CF70BD1Q37629230-00179802-8904-4DFE-9B8F-F5DFF5CD6B61Q38034037-72A58F08-8EE4-496D-BA2B-E56D8FE19F58Q38247635-97F10CD2-E075-42E1-BFC5-36540496DC30Q38261287-94D1B1FC-0843-449B-9ED7-02B3B5FEDBDBQ38290539-E0401CAB-B5F6-4B7B-95C2-3C581F40968FQ38580461-CC2C6F22-C066-44FE-B68C-D8A82C6A1A99Q38631821-05016C8C-F546-4C82-AB96-3F08590570CFQ38647611-99E98CFC-F83F-4CB1-9001-7D9CCB437217Q38668289-E4A68FCB-0DD4-454A-924F-F58091ABBF5CQ38842453-D29BCB9B-1D9F-4B7E-BA2F-29C0F803DB7AQ38935618-AB833F8F-B554-4125-A477-44F083756EC0Q39071297-58D5F9BB-5B09-42AA-A155-52BB30FC0A35Q39112299-FB3A053B-8A15-4BC2-8860-9BE0359FC21EQ40772569-95951C31-9BE6-455D-95E6-A35275C95D3DQ41124260-68ACD1EE-B29B-489D-B96A-1DC10690DD06
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Novel therapeutic approaches for pulmonary fibrosis.
@ast
Novel therapeutic approaches for pulmonary fibrosis.
@en
Novel therapeutic approaches for pulmonary fibrosis.
@nl
type
label
Novel therapeutic approaches for pulmonary fibrosis.
@ast
Novel therapeutic approaches for pulmonary fibrosis.
@en
Novel therapeutic approaches for pulmonary fibrosis.
@nl
prefLabel
Novel therapeutic approaches for pulmonary fibrosis.
@ast
Novel therapeutic approaches for pulmonary fibrosis.
@en
Novel therapeutic approaches for pulmonary fibrosis.
@nl
P2093
P2860
P1476
Novel therapeutic approaches for pulmonary fibrosis.
@en
P2093
Arnab Datta
Chris J Scotton
Rachel C Chambers
P2860
P304
P356
10.1111/J.1476-5381.2011.01247.X
P407
P577
2011-05-01T00:00:00Z